TY - JOUR
T1 - Identification of antibiotic induced persister cells in Streptococcus agalactiae
AU - Greve, Nanna Boll
AU - Slotved, Hans Christian
AU - Olsen, John Elmerdahl
AU - Thomsen, Line Elnif
N1 - Funding Information:
Funding was provided by The Independent Research Fund Denmark (grant number 0134-00155B). https://dff.dk/en/about-us? set_language=en LET recieved the funding The funder played no role in the Study design, data collection and analysis, decision to publish or preparation of the manuscript. We grateful acknowledge and thanks Dan Friis Ryttov for skillful technical assistance and Stine Yde Nielsen for providing the carrier isolates.
Publisher Copyright:
© 2024 Greve et al.
PY - 2024/6
Y1 - 2024/6
N2 - Antibiotic persistence is a phenomenon, where a small fraction of a bacterial population expresses a phenotypic variation that allows them to survive antibiotic treatment, which is lethal to the rest of the population. These cells are called persisters cells, and their occurrence has been associated with recurrent disease. Streptococcus agalactiae is a human pathobiont, able to cause invasive infections, and recurrent infections have been reported to occur in both newborns and adults. In this study, we demonstrated that S. agalactiae NEM316 can form persister cells when exposed to antibiotics from different classes. The frequency of persister cell formation was dependent on bacterial growth phase and the class of antibiotics. The ability to form persister cells in response to penicillin was shown to be a general trait among different clinical S. agalactiae isolates, independent of sero- and sequence-type. Taken together, this study shows the existence of antibiotic tolerant S. agalactiae persister cells, which may explain why this bacterial species frequently persists after treatment of invasive infection and can be associated with recurrent disease.
AB - Antibiotic persistence is a phenomenon, where a small fraction of a bacterial population expresses a phenotypic variation that allows them to survive antibiotic treatment, which is lethal to the rest of the population. These cells are called persisters cells, and their occurrence has been associated with recurrent disease. Streptococcus agalactiae is a human pathobiont, able to cause invasive infections, and recurrent infections have been reported to occur in both newborns and adults. In this study, we demonstrated that S. agalactiae NEM316 can form persister cells when exposed to antibiotics from different classes. The frequency of persister cell formation was dependent on bacterial growth phase and the class of antibiotics. The ability to form persister cells in response to penicillin was shown to be a general trait among different clinical S. agalactiae isolates, independent of sero- and sequence-type. Taken together, this study shows the existence of antibiotic tolerant S. agalactiae persister cells, which may explain why this bacterial species frequently persists after treatment of invasive infection and can be associated with recurrent disease.
UR - http://www.scopus.com/inward/record.url?scp=85196939649&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0303271
DO - 10.1371/journal.pone.0303271
M3 - Journal article
C2 - 38924011
AN - SCOPUS:85196939649
SN - 1932-6203
VL - 19
JO - PLOS ONE
JF - PLOS ONE
IS - 6 June
M1 - e0303271
ER -